H&R GmbH & Co KGaA
Company Profile
Business description
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
Contact
Neuenkirchener Strasse 8
SalzbergenNI48499
DEUT: +49 59769450
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 December 2025
Employees
1,719
Stocks News & Analysis
stocks
Investors overly negative on cheap ASX share
stocks
Overvalued US AI play reports earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,918.30 | 4.70 | 0.05% |
| CAC 40 | 8,176.29 | 25.65 | 0.31% |
| DAX 40 | 24,299.24 | 99.74 | 0.41% |
| Dow JONES (US) | 48,237.13 | 285.28 | 0.59% |
| FTSE 100 | 9,901.47 | 63.70 | 0.65% |
| HKSE | 25,690.53 | 192.40 | 0.75% |
| NASDAQ | 23,246.47 | 240.11 | 1.04% |
| Nikkei 225 | 49,507.21 | 505.71 | 1.03% |
| NZX 50 Index | 13,333.40 | 76.63 | 0.58% |
| S&P 500 | 6,828.70 | 53.94 | 0.80% |
| S&P/ASX 200 | 8,621.40 | 0.10 | -0.00% |
| SSE Composite Index | 3,890.45 | 14.08 | 0.36% |